SCHEMBL6069145

SCHEMBL6069145

CC(=O)c1ccc(Sc2ccccc2C(C)C)c(Cl)c1Cl

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 18/20 0.48
ICAM1 P05362 18/20 0.48
ITGAL P20701 18/20 0.48
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426358 0.84 ITGB2 (0.47) ITGB2ICAM1ITGALMEN1ALDH1A1
SCHEMBL6197314 0.78 ITGB2 (0.48) ITGB2ICAM1ITGAL
SCHEMBL6956020 0.75 ITGB2 (0.53) ITGB2ICAM1ITGALALDH1A1
SCHEMBL30389926 0.74 GABRA1 (0.48) ITGB2ICAM1ITGAL
SCHEMBL4808650 0.74 GABRA1 (0.48) ITGB2ICAM1ITGAL
SCHEMBL18522893 0.73 GABRA1 (0.43) KMT2A
SCHEMBL5421581 0.72 ITGB2 (0.50) ITGB2ICAM1ITGALALDH1A1
SCHEMBL7021938 0.72 ITGB2 (0.44) ITGB2ICAM1ITGAL
SCHEMBL7143425 0.72 ITGAL (0.74) ITGB2ICAM1ITGAL
SCHEMBL1635308 0.70 GABRA1 (0.50) ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066585-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS WANG GARY T 2007-03-22 US disclosed
US-20070066585-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS WANG GARY T 2007-03-22 US disclosed
US-7129247-B2 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ABBOTT LABORATORIES (US) 2006-10-31 US disclosed
US-6787542-B2 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ICOS CORPORATION 2004-09-07 US disclosed
EP-1294704-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS ABBOTT LABORATORIES (US) 2003-03-26 EP disclosed
US-20020132807-A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents ICOS CORPORATION 2002-09-19 US disclosed
WO-2002002539-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS ABBOTT LABORATORIES (US) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020132807-A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents VCAM1, ICAM1, CD47 ITGB2 70/4885ICAM1 2/4885ITGAL 97/4885
US-20070066585-A1 ARYL PHENYLHETEROCYCLYL SULFIDE DERIVATIVES AND THEIR USE AS CELL ADHESION-INHIBITING ANTI-INFLAMMATORY AND IMMUNE-SUPPRESSIVE AGENTS VCAM1, ICAM1, CD47 ITGB2 70/4885ICAM1 2/4885ITGAL 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.